These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9500773)

  • 1. Comparative analysis of histologic homologues of endometrial and ovarian carcinoma.
    Caduff RF; Svoboda-Newman SM; Bartos RE; Ferguson AW; Frank TS
    Am J Surg Pathol; 1998 Mar; 22(3):319-26. PubMed ID: 9500773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis in endometrial cancer.
    Caduff RF; Svoboda-Neumann SM; Johnston CM; Bartos RE; Frank TS
    Verh Dtsch Ges Pathol; 1997; 81():219-27. PubMed ID: 9474873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium.
    Shenson DL; Gallion HH; Powell DE; Pieretti M
    Cancer; 1995 Aug; 76(4):650-7. PubMed ID: 8625160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.
    Ambros RA; Sheehan CE; Kallakury BV; Ross JS; Malfetano J; Paunovich E; Figge J
    Mod Pathol; 1996 Dec; 9(12):1165-9. PubMed ID: 8972476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of alterations of chromosome 17 in carcinoma of the ovary and of the breast.
    Caduff RF; Svoboda-Newman SM; Ferguson AW; Frank TS
    Virchows Arch; 1999 Jun; 434(6):517-22. PubMed ID: 10394886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J
    Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.
    Demopoulos RI; Mesia AF; Mittal K; Vamvakas E
    Int J Gynecol Pathol; 1999 Jul; 18(3):233-7. PubMed ID: 12092593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
    Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
    PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
    Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
    Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
    Manavi M; Bauer M; Baghestanian M; Berger A; Kucera E; Pischinger K; Battistutti W; Czerwenka K
    Tumour Biol; 2001; 22(5):299-309. PubMed ID: 11553860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
    McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
    Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.
    Shedden KA; Kshirsagar MP; Schwartz DR; Wu R; Yu H; Misek DE; Hanash S; Katabuchi H; Ellenson LH; Fearon ER; Cho KR
    Clin Cancer Res; 2005 Mar; 11(6):2123-31. PubMed ID: 15788657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
    Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
    Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
    Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
    Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetics of epithelial ovarian neoplasms: correlations with phenotype and biological behavior].
    Diebold J
    Pathologe; 1998 Feb; 19(2):95-103. PubMed ID: 9556793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.